Strategies for Addressing Cancer Patients' Complaints of Fatigue.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 11, p. 808
- By:
- Publication type:
- Article
Works matching IS 08909091 AND DT 2017 AND VI 31 AND IP 11
Results: 9
1
2
Mucosal Melanoma: New Insights and Therapeutic Options for a Unique and Aggressive Disease.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 11, p. e23
- By:
- Publication type:
- Article
3
RESEARCH REPORTS.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 11, p. 836
- Publication type:
- Article
4
COUNTERPOINT: Which Treatment Modality for Localized Prostate Cancer Yields Superior Quality of Life: Radiotherapy or Prostatectomy?
- Published in:
- Oncology (08909091), 2017, v. 31, n. 11, p. 830
- By:
- Publication type:
- Article
5
Judy Garber on PARP inhibitors for triple-negative breast cancer.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 11, p. 814
- By:
- Publication type:
- Article
6
POINT: Which Treatment Modality for Localized Prostate Cancer Yields Superior Quality of Life: Radiotherapy or Prostatectomy?
- Published in:
- Oncology (08909091), 2017, v. 31, n. 11, p. 830
- By:
- Publication type:
- Article
7
PI3K Inhibitors: Understanding Toxicity Mechanisms and Management.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 11, p. 821
- By:
- Publication type:
- Article
8
Radical Prostatectomy for Patients With Oligometastatic Prostate Cancer.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 11, p. 794
- By:
- Publication type:
- Article
9
The Developing Role of Anti-Epidermal Growth Factor Receptor Agents in the Treatment of Advanced or Metastatic Colorectal Cancer.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 11, p. 785
- By:
- Publication type:
- Article